Dr. Marshall Schreeder

Huntsville, Alabama 35805

0 studies enrolling now · 1 studies all time

What they study most

Leukemia

Studies at this site

• A Study of Dasatinib vs. High-Dose Imatinib (600 mg) in Patients With Chronic Phase Chronic Myeloid Leukemia (CML) Who Failed to Achieve Complete Cytogenetic Response After 3-18 Months of Imatinib Therapy — Stopped early